Program Description: 

This course will provide an overview of different types of acquired thrombocytopenia.

Target audience: 

This activity is intended for physicians involved in the diagnosis and management of patients who have a low platelet count. The activity will help clinicians gain familiarity with the pathogenesis of acquired thrombocytopenias and be able to establish a differential diagnosis.

Thrombocytopenia is among the most common reason for consultation with a hematologist for both in-patients and out-patients.  There are different disorders which can cause a low platelet count and put a patient at risk for bleeding. The course will help clinicians to understand the differences among the different underlying disorders and how to appropriately manage impacted patients.

Learning objectives: 

Participants will gain basic knowledge of platelet production and the mechanisms of thrombocytopenia;

Participants will gain an understanding of the pathogenesis of acquired thrombocytopenias and be able to establish a differential diagnosis;

Participants will gain an understanding of key concepts in the clinical and laboratory diagnosis of ITP, DITP and HIT;

Participants will gain an understanding of key concepts in the management of ITP, DITP and HIT.

Faculty & credentials: 

All persons in control of the content of the course have no relevant financial disclosures except:

Module 1

Tamam Bakchoul disclosed relationships with Aspen GMbH Germany, CSL-Behring and Hämostase Update as a speaker.

Module 2

Donald Arnold has disclosed relationships with Novartis and Amgen as a researcher and with Novartis, Amgen, UCB and Rigel as a consultant.

Siraj Mithoowani disclosed a relationship with Pfizer as an educational support recipient.

Cindy Neunert disclosed a relationship with Sanofi-Genzyme as a consultant.

Module 3

Yves Gruel disclosed a relationship with Aspen as a speaker and LFB as a consultant.

François Mullier disclosed relationships with Stago, Werfen, Nodia, Sysmex and Bayer as a recipient of research support. He also disclosed relationships with Boehringer Ingelheim, Bayer Healthcare, Bristol Myers Squibb and Pfizer as a speaker.

Claire Pouplard disclosed a relationship with Stago as a contractor.

Module 4

Tamam Bakchoul disclosed relationships with Aspen GMbH Germany, CSL-Behring and Hämostase Update as a speaker.

Brian Curtis disclosed a relationship with Ionis Pharmaceuticals as an advisory board member. 

In accordance with the ACCME® standards for Commercial Support Number 6, these relationships were reviewed via the MCW conflict of interest resolution process and resolved.

CME Coordinator Contact Information

Name: 
Lacey Schmeidler
Phone number: 
+1 (919) 929-3807
Series date: 
Monday, February 25, 2019 - 8:00am to Thursday, April 30, 2020 - 12:49am

This course will provide an overview of different types of acquired thrombocytopenia.

Series location: 
ISTH Webinar Library
Carrboro, NC 27510 , NC 27510
United States

Sessions

There are no sessions in this series.